Beech Hill Advisors, Inc. Bristol Myers Squibb CO Transaction History

Beech Hill Advisors, Inc.

$255 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $13,962 - $15,830	291 Added 1.55%	19,118 $1.04 Million
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $19,392 - $23,140	-400 Reduced 2.08%	18,827 $966,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $33,286 - $37,219	-575 Reduced 2.9%	19,227 $1.12 Million
Q2 2023 Jul 10, 2023	SELL	$63.71 - $70.74 $7,135 - $7,922	-112 Reduced 0.56%	19,802 $1.27 Million
Q1 2023 Apr 14, 2023	BUY	$65.71 - $74.53 $42,711 - $48,444	650 Added 3.37%	19,914 $1.38 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $96,556 - $114,336	-1,410 Reduced 6.82%	19,264 $0
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $19 - $11,526	150 Added 0.73%	20,674 $1.47 Million
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $831,862 - $916,170	-11,455 Reduced 35.82%	20,524 $1.58 Million
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $5.61 Million - $6.72 Million	-91,178 Reduced 74.03%	31,979 $2.34 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $115,143 - $134,230	-2,147 Reduced 1.71%	123,157 $7.68 Million
Q3 2021 Oct 14, 2021	BUY	$59.17 - $69.31 $8,165 - $9,564	138 Added 0.11%	125,304 $7.41 Million
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $490,141 - $533,764	-7,917 Reduced 5.95%	125,166 $8.36 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $829,751 - $933,225	13,983 Added 11.74%	133,083 $8.4 Million
Q4 2020 Jan 22, 2021	SELL	$57.74 - $65.43 $158,785 - $179,932	-2,750 Reduced 2.26%	119,100 $7.39 Million
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $93,323 - $103,415	-1,625 Reduced 1.32%	121,850 $7.35 Million
Q2 2020 Jul 17, 2020	BUY	$54.82 - $64.09 $83,600 - $97,737	1,525 Added 1.25%	123,475 $7.26 Million
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $76,560 - $111,259	-1,650 Reduced 1.33%	121,950 $6.8 Million
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $60,282 - $78,632	-1,225 Reduced 0.98%	123,600 $7.93 Million
Q3 2019 Oct 18, 2019	SELL	$42.77 - $50.71 $80,193 - $95,081	-1,875 Reduced 1.48%	124,825 $6.33 Million
Q2 2019 Jul 15, 2019	BUY	$44.62 - $49.34 $580,060 - $641,420	13,000 Added 11.43%	126,700 $5.75 Million
Q1 2019 Apr 09, 2019	BUY	$45.12 - $53.8 $418,488 - $498,995	9,275 Added 8.88%	113,700 $5.43 Million
Q4 2018 Jan 14, 2019	SELL	$48.76 - $63.23 $52,417 - $67,972	-1,075 Reduced 1.02%	104,425 $5.43 Million
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $46,911 - $52,912	850 Added 0.81%	105,500 $6.55 Million
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $70,742 - $88,172	-1,400 Reduced 1.32%	104,650 $5.79 Million
Q1 2018 Apr 23, 2018	SELL	$59.92 - $68.98 $218,708 - $251,777	-3,650 Reduced 3.33%	106,050 $6.71 Million
Q4 2017 Jan 23, 2018	BUY	$59.94 - $65.35 $2,997 - $3,267	50 Added 0.05%	109,700 $6.72 Million
Q3 2017 Oct 20, 2017	BUY	$55.23 - $63.74 $6.06 Million - $6.99 Million	109,650	109,650 $6.99 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beech Hill Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beech Hill Advisors, Inc. with notifications on news.

Account